Last update 28 Mar 2025

TR-009

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
ABL-001, ABL-001-ABL BIO, ABL001-ABL BIO
+ [6]
Action
inhibitors
Mechanism
DLL4 inhibitors(Delta-like protein 4 inhibitors), VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 2/3
First Approval Date-
RegulationFast Track (United States)
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bile Duct NeoplasmsPhase 3
United States
09 Jan 2023
Carcinoma of ampulla of VaterPhase 3
United States
09 Jan 2023
Gallbladder CarcinomaPhase 3
United States
09 Jan 2023
Biliary Tract NeoplasmsPhase 3
United States
-
Metastatic Biliary Tract CarcinomaPhase 2
United States
22 Jan 2025
Metastatic Biliary Tract CarcinomaPhase 2
United States
22 Jan 2025
Colonic CancerPhase 2
United States
08 Dec 2022
Rectal CancerPhase 2
United States
08 Dec 2022
Metastatic Colorectal CarcinomaPhase 2
China
25 Feb 2022
Colorectal CancerPhase 2
China
11 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
24
CTX-009 10 mg/kg+paclitaxel 80 mg/m2
yoarlzjrrh(qlxekcnemx) = kqaafqocfl jbreofggyr (boktdncuvg, 18.8 - 59.4)
Positive
24 Jan 2023
Phase 2
24
paclitaxel+ES104
mwdvqzribz(zwvwfavmqp) = qtakuirjeh xwbvtzwerz (mnonxnoypb )
Positive
05 May 2022
Phase 2
24
Paclitaxel+CTX-009
mxefhueyqs(fkugoyogdv) = ulptnulwer vpjexiqbja (mqyebbdqdj )
Positive
04 May 2022
Phase 1
45
wkdepsihis(knvuokomie) = 10.0 and 12.5 mg/kg biweekly lwefjvopdg (bldwplveok )
Positive
08 Oct 2021
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free